post ERCP pancreatitis. Other acute pancreatitis
Conditions
Interventions
Intervention 1: Group 1: Solution ringer lactate bolus 20 cc/kg then 3 cc/kg/h for 8 hours. Intervention 2: Group 2: Indomethacin rectally every 12 hours for 24 hours. Intervention 3: Group 3: Placebo
Treatment - Drugs
Placebo
Group 1: Solution ringer lactate bolus 20 cc/kg then 3 cc/kg/h for 8 hours.
Group 2: Indomethacin rectally every 12 hours for 24 hours
Group 3: Placebo
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: hospitalized patients who underwent Endoscopic Retrograde Cholangiopancreatography (ERCP) Exclusion criteria: acute cholongitis; sepsis; chronic pancreatitis; acute pancreatitis due to gallstones; patients at risk of increasing fluid volume; pregnant women; patient undergoing papilla dilatation; history of pancreatitis after ERCP; patients with stent embedded in pancreatic duct.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pancreatitis. Timepoint: 8 hours and 24 hours after ERCP procedure. Method of measurement: Abdominal pain plus amylase level over 270 IU/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Shajirat
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed